EPITAN - Clinuvel Pharmaceuticals

EPITANhas a Pharmacy degree, post-graduate qualifications from Sydney University andHealth Economics qualifications from Monash University, Melbourne.ConsultantsDr Perry RobinsMedical Advisory ConsultantDr Perry Robins is a New York-based skin cancer specialist. He is a full Professor ofDermatology and Chief of the Mohs Micrographic Surgery Unit at New York UniversityMedical Center. Dr Robins has joined EpiTan as a Medical Advisory Consultant tofacilitate the expansion of EpiTan's clinical trials into the US and Europe.Dr Robins has practiced medicine for over thirty-five years, treating more than 40,000skin cancer patients. As an accomplished educator in his field, Dr Robins has trainedsixty doctors from around the world who are now leaders in dermatologic and skincancer care, and he has lectured in thirty-four countries. At present, he performs morethan 1,000 surgical procedures annually and conducts training workshops for his peersin advanced techniques of dermatologic surgery.Dr Robins is founder and president of the Skin Cancer Foundation, an internationalorganisation dedicated to skin cancer research and education. The advisory board andmedical councils of the Skin Cancer Foundation comprise more than 144 leadinginternational physicians who are distinguished members of the scientific and medicalcommunities and members of the business and professional sectors.Dr Robins is also the founder/president of the International Society of DermatologicSurgery, founder/former president of the American College of Mohs MicrographicSurgery, and former president of the American Society of Dermatologic Surgery.Dr Ella ToombsRegulatory Advisory ConsultantDr Toombs was a dermatology specialist with the FDA for 13 years. Her primary focusis to assist EpiTan prepare its IND application for MELANOTAN.Dr Toombs spent ten years with the FDA Division of Dermatologic Drugs. During thistime Dr Toombs reviewed numerous IND proposals for novel drug applications andtraditional dermatologics.Dr Toombs is the Washington DC representative on the advisory board of theAmerican Academy of Dermatology and a member of the National Medical Associationand American Association of Pharmaceutical Physicians.She is currently a consultant in private practice specialising in aesthetic dermatology.Medical Advisory PanelEpiTan has also established a Medical Advisory Panel of leading dermatologists. ThePanel is made up of Dr Peter Foley (Chairperson), Senior Lecturer Dermatology, St.Vincent’s Hospital, University of Melbourne; Dr Chris Baker, Director of ClinicalDermatology, St Vincent’s Hospital, Melbourne; Professor Ross Barneston, Head ofDermatology, Royal Alfred Hospital, Sydney; and Dr James Muir, Head ofDermatology, Mater Hospital, Brisbane.Non-Executive DirectorsDr Wayne MillenNon-executive ChairmanDr Millen is the founding Managing Director of EpiTan. He has a PhD in chemistry andbiochemistry from the University of Western Australia and is a Chartered Chemist withover 35 years experience operating his own commercial enterprises.Dr Millen has extensive experience in venture and development capital investment withan emphasis on companies involved in technological innovation and has been the leadinvestor and strategist in several private and public companies.23